DOI: 10.12890/2024_004870
DIPNECH: a rare cause of slow-growing pulmonary nodules in a dyspnoeic patient with a history of breast cancer
Authors
dion_buhagiar@live.com
Keywords
DIPNECH, diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndromeAbstract
A middle-aged woman undergoing a computed tomography scan while being investigated for a retrosternal goitre, was found to have several solid intrapulmonary nodules of varying sizes with mosaic attenuation of lung parenchyma. After serial radiology follow-up, a radiologist with a special interest in thoracic imaging made the tentative diagnosis of diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) during discussions at the local multidisciplinary team meeting. Radionuclide imaging was performed to assist in reaching a diagnosis. Uptake of DOTATATE by the pulmonary nodules on a background of mosaic attenuation pattern supported a diagnosis of DIPNECH. Potential secondary metastatic disease from previous breast malignancy confounded a possible earlier diagnosis of DIPNECH, with subsequent diagnostic imaging modalities leading to the rare diagnosis. The patient was treated symptomatically with oral steroids with no improvement, and subsequently with octreotide which significantly improved her condition.
References
- Rossi G, Cavazza A, Spagnolo P, Sverzellati N, Longo L, Jukna A, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia syndrome. Eur Respir J 2016;47:1829–1841.
- Koliakos E, Thomopoulos T, Abbassi Z, Duc C, Christodoulou M. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a case report and review of the literature. Am J Med Case Rep 2017;18:975–979.
- Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol 2015;9:1240–1242.
- Davies SJ, Gosney JR, Hansell DM, Wells AU, du Bois RM, Burke MM, et al. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax 2007;62:248–252.
- Prasad V, Steffen IG, Pavel M, Denecke T, Tischer E, Apostolopoulou K, et al. Somatostatin receptor PET/CT in restaging of typical and atypical lung carcinoids. EJNMMI Res 2015;5:53.
- Nassar AA, Jaroszewski DE, Helmers RA, Colby TV, Patel BM, Mookadam F. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: a systematic overview. Am J Respir Crit Care Med 2011;184:8–16.
- Sazonova O, Manem V, Béland C, Hamel MA, Lacasse Y, Lévesque MH, et al. Development and validation of diffuse idiopathic pulmonary neuroendocrine hyperplasia diagnostic criteria. JTO Clin Res Rep 2020;1:100078.
- Babalola O, Muskrat J, Kanchustambham V. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH) progressing to carcinoid tumor: a case of chronic cough. Cureus 2023;15: e46659.
